230 related articles for article (PubMed ID: 17306234)
1. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.
Clifford PM; Zarrabi S; Siu G; Kinsler KJ; Kosciuk MC; Venkataraman V; D'Andrea MR; Dinsmore S; Nagele RG
Brain Res; 2007 Apr; 1142():223-36. PubMed ID: 17306234
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
[TBL] [Abstract][Full Text] [Related]
3. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
[TBL] [Abstract][Full Text] [Related]
4. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
6. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
7. Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier.
Banks WA; Niehoff ML; Drago D; Zatta P
Brain Res; 2006 Oct; 1116(1):215-21. PubMed ID: 16942756
[TBL] [Abstract][Full Text] [Related]
8. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques.
Miyawaki K; Nakayama H; Matsuno S; Tamaoka A; Doi K
Acta Neuropathol; 2002 Mar; 103(3):228-36. PubMed ID: 11907802
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
[TBL] [Abstract][Full Text] [Related]
11. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.
Bateman DA; McLaurin J; Chakrabartty A
BMC Neurosci; 2007 May; 8():29. PubMed ID: 17475015
[TBL] [Abstract][Full Text] [Related]
12. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
14. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
Nagele RG; Clifford PM; Siu G; Levin EC; Acharya NK; Han M; Kosciuk MC; Venkataraman V; Zavareh S; Zarrabi S; Kinsler K; Thaker NG; Nagele EP; Dash J; Wang HY; Levitas A
J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
[TBL] [Abstract][Full Text] [Related]
15. Plasma Abeta levels do not reflect brain Abeta levels.
Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
[TBL] [Abstract][Full Text] [Related]
16. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
17. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
[TBL] [Abstract][Full Text] [Related]
18. Amyloid and Tau accumulate in the brains of aged hydrocephalic rats.
Silverberg GD; Miller MC; Machan JT; Johanson CE; Caralopoulos IN; Pascale CL; Heile A; Klinge PM
Brain Res; 2010 Mar; 1317():286-96. PubMed ID: 20045398
[TBL] [Abstract][Full Text] [Related]
19. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
20. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.
Poduslo JF; Curran GL; Kumar A; Frangione B; Soto C
J Neurobiol; 1999 Jun; 39(3):371-82. PubMed ID: 10363910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
